Embody vs Start Willow: Price, Shipping, and Compounded Options
Quick comparison: Embody vs Start Willow
Short verdict: Embody is the lower-cost, no-frills option with compounded semaglutide from $69/month and 1–2 day free shipping after approval; Start Willow costs from $249/month (rising to $299 ongoing) and emphasizes personalized clinician collaboration with delivery in 3 days or less.
See Embody pricing and options
How these programs differ at a glance
This comparison focuses on five clear, supported differences: price and pricing model, shipping speed, medication positioning and regulatory notes, personalization and features, and who each provider is best for. Every claim below is stated using the source language and qualifiers provided.
Price and pricing model
Embody: Compounded semaglutide is offered at $69/month (noted as cut from $299), with compounded tirzepatide at $119/month. Embody markets flat locked-in monthly pricing, no monthly membership, and cancel anytime. Start Willow: Priced from $249 for the first month and $299/month ongoing; no membership fees but the ongoing $299/month is described as higher than many alternatives.
Shipping and delivery
Embody advertises free shipping with delivery in 1–2 days after clinician approval. Start Willow guarantees delivery in 3 days or less and lists same day prescriptions with free 2-day shipping in other captured material. Both providers describe fast delivery windows from licensed pharmacies; Embody emphasizes 1–2 day arrival while Start Willow emphasizes a 3-day or less guarantee.
Medication type, branding, and regulatory notes
Both providers offer compounded semaglutide and state their compounded medications are not FDA-approved finished products. Embody explicitly notes its offerings are compounded semaglutide and compounded tirzepatide and repeats that compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Start Willow describes medications comparable to branded Ozempic and tirzepatide but likewise states that compounded semaglutide is not FDA-approved and that compounding pharmacies operate under state board oversight and USP standards.
Personalization, clinical review, and platform features
Start Willow positions its semaglutide as a customized treatment “designed in collaboration with your Willow doctor as part of your individualized care plan,” highlighting personalization for patients with specific health profiles or treatment goals. Embody emphasizes a prescription and telemed visit model, licensed provider review handled entirely online, and 24/7 support access for dosing and side-effect questions, but notes it has fewer premium features such as integrated coaching or advanced monitoring compared with higher-priced platforms.
Direct comparison table
| Criteria | Embody | Start Willow |
|---|---|---|
| Starting price | $69/month for compounded semaglutide; $119/month tirzepatide | From $249 first month; $299/month ongoing |
| Shipping speed | Free shipping; arrives in 1–2 days after approval | Delivery guaranteed in 3 days or less; same-day prescriptions noted |
| Medication type | Compounded semaglutide and tirzepatide; not FDA-approved finished products | Compounded semaglutide comparable to Ozempic and tirzepatide; not FDA-approved finished products |
| Personalization and care | Online licensed provider review and telemed visits; fewer premium features | Personalized treatment plan designed with Willow doctor; emphasizes clinician collaboration |
| Membership and insurance | No monthly membership; no insurance required | No membership fees; no insurance required; direct-pay model |
Safety and regulatory language
Both sources explicitly state that their compounded medications are not FDA-approved finished products and that the FDA does not review compounded medications for safety, effectiveness, or quality. Start Willow adds that compounded medications are prepared by state-licensed compounding pharmacies operating under state board oversight and USP compounding standards.
Patient experience and trade-offs
Embody markets itself as “best for cost-driven patients” who want a straightforward program without premium add-ons, highlighting low entry price and fast 1–2 day shipping. Start Willow is described as best for patients frustrated by insurance pre-authorization, offering a direct-pay model and clinician collaboration, but with ongoing pricing that may be higher than many alternatives.
See Start Willow plans and timeline
Bottom line and who should choose which
Embody vs Start Willow comes down to cost and personalization. Embody delivers the lowest entry price and the fastest advertised shipping window, while Start Willow emphasizes clinician collaboration, a tailored plan, and a delivery guarantee but at a higher ongoing cost.
Review Start Willow’s clinician-guided options
Compare Embody’s low-cost offerings
Choose Embody if…
You prioritize the lowest possible monthly entry price for compounded semaglutide or tirzepatide, want free 1–2 day shipping after approval, prefer a simple telehealth prescription model with no membership, and accept that medications are compounded and not FDA-approved finished products.
Choose Start Willow if…
You value a personalized, clinician-collaborative treatment plan and want a provider that emphasizes tailored medication design and a 3-day delivery guarantee, and you accept a higher ongoing cost that starts from $249 and typically moves to $299/month.